James Douglas Hunter
Keine laufenden Positionen mehr
Profil
James Douglas Hunter served as Secretary, Director & Finance Director at Proximagen Group Plc from 2010 to 2012.
He was a Director at Minster Pharmaceuticals Plc.
From 2014 to 2016, he served as CFO, Secretary & Executive Director at Venture Life Group Plc.
Mr. Hunter holds an MBA from Cranfield School of Management.
Ehemalige bekannte Positionen von James Douglas Hunter
Unternehmen | Position | Ende |
---|---|---|
VENTURE LIFE GROUP PLC | Finanzdirektor/CFO | 30.11.2016 |
Minster Pharmaceuticals Plc
Minster Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Minster Pharmaceuticals Plc develops pharmaceutical compounds for the treatment of neurological and psychiatric conditions. The company operates in Tonabersat and Sabcomeline segments. The Tonabersat segment is for the prevention and treatment of migraine. The Sabcomeline segment is for the management of cognitive decline and negative symptoms in schizophrenia. Minster Pharmaceuticals was founded by Robert Stubbs and Paul Sharpe in 2001 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Proximagen Group Plc
Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Finanzdirektor/CFO | - |
Ausbildung von James Douglas Hunter
Cranfield School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VENTURE LIFE GROUP PLC | Health Technology |
Private Unternehmen | 2 |
---|---|
Proximagen Group Plc
Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Minster Pharmaceuticals Plc
Minster Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Minster Pharmaceuticals Plc develops pharmaceutical compounds for the treatment of neurological and psychiatric conditions. The company operates in Tonabersat and Sabcomeline segments. The Tonabersat segment is for the prevention and treatment of migraine. The Sabcomeline segment is for the management of cognitive decline and negative symptoms in schizophrenia. Minster Pharmaceuticals was founded by Robert Stubbs and Paul Sharpe in 2001 and is headquartered in London, the United Kingdom. | Health Technology |